The GISTs without mutations in KIT, PDGFRA, SDH, or BRAF/RAS/NF1 (RAS-Pathway) were termed ‘quadruple WT’ GISTs [11] whose diverse molecular alterations and tumor biological behaviors remain unclear. This evidence concerns the gene NF1 and neoplasm.